wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28077785-01E91D06-4721-40F6-A1DC-3564805B7783
Q28077785-01E91D06-4721-40F6-A1DC-3564805B7783
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077785-01E91D06-4721-40F6-A1DC-3564805B7783
Mechanism of c-MET in Non-small Cell Lung Cancer and Its Treatment and Testing
P2860
Q28077785-01E91D06-4721-40F6-A1DC-3564805B7783
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077785-01E91D06-4721-40F6-A1DC-3564805B7783
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
42b17a0cf0869e7077e70e00c3cec52e059fa0ec
P2860
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epi